Search - tctmd.com

Displaying 1 - 20 of 38

Sort: Relevancy | Date

News Daily News

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

L.A. McKeown

December 12, 2024

News Opinion CV Team Dispatch

September 2024 Dispatch for the CV Team

L.A. McKeown

September 01, 2024

News Conference News SCAI 2024

Women, Black Patients Less Likely to Get Advanced PE Therapy, Analysis Shows

L.A. McKeown

May 06, 2024

News Opinion CV Team Dispatch

November 2023 News Roundup

L.A. McKeown

November 01, 2023

News Daily News

Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel

L.A. McKeown

August 23, 2023

News Daily News

As Renal Denervation Heads to Advisory Review, FDA Sets Out Key Questions

L.A. McKeown

August 18, 2023

News Conference News CRT 2023

Renal Denervation in Black Patients: SYMPLICITY HTN 3 Reassures at 36 Months

Yael L. Maxwell

February 28, 2023

News Daily News

Reduction in BP Drives Treatment Preference for Hypertensive Patients

Michael O'Riordan

December 20, 2022

News Conference News AHA 2022

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

Todd Neale

November 09, 2022

News Conference News TCT 2022

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

Michael O'Riordan

September 19, 2022

News Opinion CV Team Dispatch

September 2022 News Roundup

L.A. McKeown

September 01, 2022

News Opinion CV Team Dispatch

January 2022 News Roundup

L.A. McKeown

January 01, 2022

News Opinion CV Team Dispatch

December 2021 News Roundup

L.A. McKeown

December 01, 2021

News Opinion CV Team Dispatch

November 2021 News Roundup

L.A. McKeown

November 01, 2021

News Conference News TCT 2021

NSTEMI Patients With CKD See Better Outcomes With Invasive Strategy

L.A. McKeown

October 22, 2021

News Daily News

Renal Denervation a Third Option for Hypertension, European Experts Say

Todd Neale

September 17, 2021

News Conference News ACC 2021

Renal Denervation Lowers BP vs Sham Procedure: RADIANCE-HTN TRIO

Michael O'Riordan

May 16, 2021

News Conference News TCT 2020

Treating Accessory Arteries May Be Important in Renal Denervation

Todd Neale

October 18, 2020

News Daily News

Renal Function Gains Seen in CKD Patients After TAVR

L.A. McKeown

September 15, 2020

News Daily News

Longer Patency, Fewer Repeat Procedures With Paclitaxel DCBs in Dialysis Patients

L.A. McKeown

August 21, 2020

Advertisement

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

September 2024 Dispatch for the CV Team

Women, Black Patients Less Likely to Get Advanced PE Therapy, Analysis Shows

November 2023 News Roundup

Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel

As Renal Denervation Heads to Advisory Review, FDA Sets Out Key Questions

Renal Denervation in Black Patients: SYMPLICITY HTN 3 Reassures at 36 Months

Reduction in BP Drives Treatment Preference for Hypertensive Patients

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

September 2022 News Roundup

January 2022 News Roundup

December 2021 News Roundup

November 2021 News Roundup

NSTEMI Patients With CKD See Better Outcomes With Invasive Strategy

Renal Denervation a Third Option for Hypertension, European Experts Say

Renal Denervation Lowers BP vs Sham Procedure: RADIANCE-HTN TRIO

Treating Accessory Arteries May Be Important in Renal Denervation

Renal Function Gains Seen in CKD Patients After TAVR

Longer Patency, Fewer Repeat Procedures With Paclitaxel DCBs in Dialysis Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content